Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:01
Dear Readers,
New—a word that confuses and causes even the strongest to tremble. Why do we need new? Walt Disney said, “We keep moving forward, opening new doors, and doing new things because we’re curious, and curiosity keeps leading us down new paths.”
- Issue:01
Disclosure: Financial support for this study was provided by the University of Hertfordshire.
- Issue:01
Since 2003, countermeasure for pressure ulcer development has played an active part in preventing the development of pressure ulcers at the National Nagasaki Medical Center. However, new pressure ulcers continue to develop and it has become clear that half of these patients have cancer as an underlying disease (Figure 1).1 Terminally ill patients must be treated with consideration of their quality of life and should not be urged to undergo intensive or invasive therapy.
- Issue:01
Pressure ulcers (PU) are defined as skin breakdown and continuum of tissue damage of ischemic etiology secondary to high external pressure, which usually occurs over bony prominences.1 Seventeen percent of hospitalized patients have or will end up having a PU. In the worldwide geriatric population, 71% of patients ≥ 70 years have PU.2 According to Brazilian estimations, 14% of the population will be 60 years old or more by 2025.3 In Brazil, national policy considers elderly citizens to be 60 years old or older.4
- Issue:01
Department Editor
Tania J. Phillips, MD, FRCPCOverall Learning Objective: The physician or nurse participant will develop a rational approach to the evaluation and treatment of a variety of uncommon wounds and will have an increased awareness of the differential diagnosis of cutaneous wounds and the systemic diseases associated with these wounds.
- Issue:01
KCI’s Wound Care Products Approved for Military Aircraft Use
- Issue:01
Insulin Application Significantly Enhances Wound Healing
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
